Selenium supplementation does not seem to add benefits to patients with Graves ophthalmopathy who live in already selenium-sufficient areas.

Optic neuropathy and recurrence of papilledema in patients with craniosynostosis may be a clinically useful biomarker by PHOMS.

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Researchers found that older, healthy individuals with lower, yet normal, levels of B12 exhibited signs of neurological and ...

The countdown is on until 01 March which marks the start of New Zealand’s annual Glaucoma Awareness Month.

Meeting the minimum requirement for vitamin B12, needed to make DNA, red blood cells and nerve tissue, may not actually be enough – particularly if ...

A study found that B12 requirements may be too low for some people, putting them at risk for cognitive decline.

Demand is expected to outstrip supply for the foreseeable future. The latest prediction: The shortfall of physicians could ...

In the bustling world of weight-loss drugs, where medications like Ozempic and Wegovy have been hailed as straight-up ...

In this Healio Video Perspective from Telling It Like It Is, Andrew G. Lee, MD, explains why a team approach is needed for neuro-ophthalmic conditions.